G-Protein-Coupled Lysophosphatidic Acid Receptors and Their Regulation of AKT Signaling
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
A hallmark of G-protein-coupled receptors (GPCRs) is their ability to recognize and respond to chemically diverse ligands. Lysophospholipids constitute a relatively recent addition to these ligands and carry out their biological functions by activating G-proteins coupled to a large family of cell-surface receptors. This review aims to highlight salient features of cell signaling by one class of these receptors, known as lysophosphatidic acid (LPA) receptors, in the context of phosphatidylinositol 3-kinase (PI3K)–AKT pathway activation. LPA moieties efficiently activate AKT phosphorylation and activation in a multitude of cell types. The interplay between LPA, its receptors, the associated Gαi/o subunits, PI3K and AKT contributes to the regulation of cell survival, migration, proliferation and confers chemotherapy-resistance in certain cancers. However, detailed information on the regulation of PI3K–AKT signals induced by LPA receptors is missing from the literature. Here, some urgent issues for investigation are highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“LPAR5 belongs to the lysophosphatidic acid receptor family, which are G-protein coupled receptors (GPCR) that activate the PI3K-AKT signaling pathway57”
From Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities (2018) · cites this paper as [57]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The functions and regulation of the PTEN tumour suppressor
Song, M. S., Salmena, L., & Pandolfi, P. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3330 · Cited by 1,926
The emerging mechanisms of isoform-specific PI3K signalling
Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M., & Bilanges, B. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2882 · Cited by 1,767 · cited 1×
“Some PI3Ks can be activated by binding of the regulatory subunit to specific phosphorylated tyrosines in cell surface receptors or adaptor proteins and by binding of the catalytic subunit to GTP-RAS [84,85].”
BackgroundRodriguez-Viciana, P., Sabatier, C., & McCormick, F. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4943-4954.2004 · Cited by 327 · cited 2×
“Integrins also induce PI3K activity, which at least for β1-integrins occurs through p110α [89,90]. p110α and p110γ can interact with several RAS proteins, including H-, N-, K-, R-RAS and TC21, while p110δ interacts with R-RAS and TC21 [91].”
Background
Research works printed but not linked: 102
- Choi, 2010, Lpa receptors: Subtypes and biological actions, Annu. Rev. Pharmacol. Toxicol., 50, 157, 10.1146/annurev.pharmtox.010909.105753 · DOI · Paper page
- Moolenaar, 1999, Bioactive lysophospholipids and their G protein-coupled receptors, Exp. Cell Res., 253, 230, 10.1006/excr.1999.4702 · DOI · Paper page
- Aoki, 2002, Serum lysophosphatidic acid is produced through diverse phospholipase pathways, J. Biol. Chem., 277, 48737, 10.1074/jbc.M206812200 · DOI · Paper page
- Choi, 2013, Lysophospholipids and their receptors in the central nervous system, Biochim. Biophys. Acta, 1831, 20, 10.1016/j.bbalip.2012.07.015 · DOI · Paper page
- Yung, 2014, Lpa receptor signaling: Pharmacology, physiology, and pathophysiology, J. Lipid Res., 55, 1192, 10.1194/jlr.R046458 · DOI · Paper page
- Hama, 2002, Lysophosphatidic acid (Lpa) receptors are activated differentially by biological fluids: Possible role of lpa-binding proteins in activation of lpa receptors, FEBS Lett., 523, 187, 10.1016/S0014-5793(02)02976-9 · DOI
- Bandoh, 2000, Lysophosphatidic acid (Lpa) receptors of the edg family are differentially activated by lpa species: Structure–activity relationship of cloned Lpa receptors, FEBS Lett., 478, 159, 10.1016/S0014-5793(00)01827-5 · DOI · Paper page
- Aoki, 2008, Two pathways for lysophosphatidic acid production, Biochim. Biophys. Acta (BBA), 1781, 513, 10.1016/j.bbalip.2008.06.005 · DOI · Paper page
- Moolenaar, 2011, Insights into autotaxin: How to produce and present a lipid mediator, Nat. Rev., 12, 674, 10.1038/nrm3188 · DOI · Paper page
- Blaho, 2011, Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors, Chem. Rev., 111, 6299, 10.1021/cr200273u · DOI · Paper page
- Okudaira, 2010, Biological roles of lysophosphatidic acid signaling through its production by autotaxin, Biochimie, 92, 698, 10.1016/j.biochi.2010.04.015 · DOI · Paper page
- Houben, 2011, Autotaxin and lpa receptor signaling in cancer, Cancer Metastasis Rev., 30, 557, 10.1007/s10555-011-9319-7 · DOI · Paper page
- Stracke, 1992, Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein, J. Biol. Chem., 267, 2524, 10.1016/S0021-9258(18)45911-X · DOI · Paper page
- Lee, 1996, Cloning, chromosomal localization, and tissue expression of autotaxin from human teratocarcinoma cells, Biochem. Biophys. Res. Commun., 218, 714, 10.1006/bbrc.1996.0127 · doi:10.1006/bbrc.1996.0127
- Perrakis, 2014, Autotaxin: Structure-function and signaling, J. Lipid Res., 55, 1010, 10.1194/jlr.R046391 · DOI · Paper page
- Zhang, 2012, Autotaxin through lysophosphatidic acid stimulates polarization, motility, and transendothelial migration of naive t cells, J. Immunol., 189, 3914, 10.4049/jimmunol.1201604 · DOI
- Teo, 2009, Lysophosphatidic acid (lpa) in vascular development and disease, IUBMB Life, 61, 791, 10.1002/iub.220 · doi:10.1002/iub.220
- Fukushima, 2002, Neurobiology of lysophosphatidic acid signaling, The Neurosci.: Rev. J. Bringing Neurobiol. Neurol. Psychiatry, 8, 540
- Spohr, 2008, Lysophosphatidic acid receptor-dependent secondary effects via astrocytes promote neuronal differentiation, J. Biol. Chem., 283, 7470, 10.1074/jbc.M707758200 · DOI
- Ye, 2002, Lysophosphatidic acid in neural signaling, Neuroreport, 13, 2169, 10.1097/00001756-200212030-00002 · DOI
- Yung, 2011, Lysophosphatidic acid signaling may initiate fetal hydrocephalus, Sci. Transl. Med., 3, 99ra87, 10.1126/scitranslmed.3002095 · DOI
- Yung, 2015, Lysophosphatidic acid signaling in the nervous system, Neuron, 85, 669, 10.1016/j.neuron.2015.01.009 · DOI · Paper page
- Knowlden, 2014, The autotaxin-lpa axis emerges as a novel regulator of lymphocyte homing and inflammation, J. Immunol., 192, 851, 10.4049/jimmunol.1302831 · DOI · Paper page
- Gennero, 2011, Absence of the lysophosphatidic acid receptor lpa1 results in abnormal bone development and decreased bone mass, Bone, 49, 395, 10.1016/j.bone.2011.04.018 · doi:10.1016/j.bone.2011.04.018
- Ye, 2010, Lysophosphatidic acid (Lpa) signaling in vertebrate reproduction, Trends Endocrinol. Metab.: TEM, 21, 17, 10.1016/j.tem.2009.08.003 · DOI
- Sims, 2013, Lysophosphatidic acid: A potential mediator of osteoblast-osteoclast signaling in bone, Biochim. Biophys. Acta, 1831, 109, 10.1016/j.bbalip.2012.08.001 · DOI
- Tsujiuchi, 2014, Lysophosphatidic acid receptors in cancer pathobiology, Histol. Histopathol., 29, 313
- Tsujiuchi, 2014, Diverse effects of lpa receptors on cell motile activities of cancer cells, J. Recept. Signal Transduct. Res., 34, 149, 10.3109/10799893.2013.876042 · DOI
- Yang, 2013, Migration of gastric cancer cells in response to lysophosphatidic acid is mediated by lpa receptor 2, Oncol. Lett., 5, 1048, 10.3892/ol.2013.1107 · doi:10.3892/ol.2013.1107
- Sokolov, 2013, Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma, J. Surg. Res., 180, 104, 10.1016/j.jss.2012.10.054 · DOI
- Popnikolov, 2012, Association of autotaxin and lysophosphatidic acid receptor 3 with aggressiveness of human breast carcinoma, Tumour Biol.: J. Int. Soc. Oncodev. Biol. Med., 33, 2237, 10.1007/s13277-012-0485-1 · DOI
- Komachi, 2012, Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo, Cancer Sci., 103, 1099, 10.1111/j.1349-7006.2012.02246.x · DOI
- Sako, 2006, Lysophosphatidic acid (Lpa)-induced vascular endothelial growth factor (Vegf) by mesothelial cells and quantification of host-derived vegf in malignant ascites, J. Surg. Res., 130, 94, 10.1016/j.jss.2005.08.007 · DOI
- Lin, 2008, Lysophosphatidic acid up-regulates vascular endothelial growth factor-c and lymphatic marker expressions in human endothelial cells, Cell. Mol. Life Sci., 65, 2740, 10.1007/s00018-008-8314-9 · DOI
- Samadi, 2011, Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance, Biochimie, 93, 61, 10.1016/j.biochi.2010.08.002 · DOI
- Sui, 2015, Lysophosphatidic acid inhibits apoptosis induced by cisplatin in cervical cancer cells, BioMed Res. Int., 2015, 598386, 10.1155/2015/598386 · doi:10.1155/2015/598386
- Venkatraman, 2015, Lysophosphatidate signaling stabilizes nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: Implications for cancer treatment, FASEB J. Off. Publ. Federation Am. Soc. Exp. Biol., 29, 772, 10.1096/fj.14-262659 · DOI
- Sheng, 2015, Lysophosphatidic acid signalling in development, Development, 142, 1390, 10.1242/dev.121723 · DOI
- Fukushima, 2015, Comparative analyses of lysophosphatidic acid receptor-mediated signaling, Cell. Mol. Life Sci. CMLS, 72, 2377, 10.1007/s00018-015-1872-8 · DOI
- Xiang, 2013, Lysophospholipid receptor activation of rhoa and lipid signaling pathways, Biochim. Biophys. Acta, 1831, 213, 10.1016/j.bbalip.2012.09.004 · DOI
- Olivo, 2003, Rac activation by lysophosphatidic acid lpa1receptors through the guanine nucleotide exchange factor tiam1, J. Biol. Chem., 278, 400, 10.1074/jbc.M210151200 · DOI · Paper page
- Fang, 2000, Lysophosphatidic acid prevents apoptosis in fibroblasts via g(I)-protein-mediated activation of mitogen-activated protein kinase, Biochem. J., 352 Pt 1, 135, 10.1042/bj3520135 · doi:10.1042/bj3520135
- Ye, 2002, Lysophosphatidic acid as a novel cell survival/apoptotic factor, Biochim. Biophys. Acta, 1585, 108, 10.1016/S1388-1981(02)00330-X · DOI
- Bjorklof, 2008, The p110beta isoform of phosphoinositide 3-kinase signals downstream of g protein-coupled receptors and is functionally redundant with p110gamma, Proc. Natl. Acad. Sci. USA, 105, 8292, 10.1073/pnas.0707761105 · DOI · Paper page
- Hildebrandt, 1995, Lysophosphatidic acid induces inositol phosphate and calcium signals in exocrine cells from the avian nasal salt gland, J. Membarin Biol., 144, 49, 10.1007/BF00238416 · doi:10.1007/bf00238416
- Gennero, 1999, Effects of lysophosphatidic acid on proliferation and cytosolic ca++ of human adult vascular smooth muscle cells in culture, Thromb. Res., 94, 317, 10.1016/S0049-3848(99)00004-3 · DOI
- Litosch, 2009, Phosphatidic acid potentiates gαq stimulation of phospholipase c-β1 signaling, Biochem. Biophys. Res. Commun., 390, 603, 10.1016/j.bbrc.2009.10.013 · DOI
- Lee, 2007, Lpa4/gpr23 is a lysophosphatidic acid (Lpa) receptor utilizing gs-, gq/gi-mediated calcium signaling and g12/13-mediated rho activation, J. Biol. Chem., 282, 4310, 10.1074/jbc.M610826200 · DOI · Paper page
- Wittpoth, 1999, Regions on adenylyl cyclase that are necessary for inhibition of activity by βγ and g(Iα) subunits of heterotrimeric g proteins, Proc. Natl. Acad. Sci. USA, 96, 9551, 10.1073/pnas.96.17.9551 · DOI
- Takuwa, 2002, The edg family g protein-coupled receptors for lysophospholipids: Their signaling properties and biological activities, J. Biochem., 131, 767, 10.1093/oxfordjournals.jbchem.a003163 · DOI · Paper page
- Hecht, 1996, Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex, J. Cell Biol., 135, 1071, 10.1083/jcb.135.4.1071 · DOI · Paper page
- Lee, 1998, Sphingosine-1-phosphate as a ligand for the g protein-coupled receptor edg-1, Science, 279, 1552, 10.1126/science.279.5356.1552 · DOI · Paper page
- Contos, 2000, Genomic characterization of the lysophosphatidic acid receptor gene, lpa2/edg4, and identification of a frameshift mutation in a previously characterized cdna, Genomics, 64, 155, 10.1006/geno.2000.6122 · DOI
- Bandoh, 1999, Molecular cloning and characterization of a novel human g-protein-coupled receptor, edg7, for lysophosphatidic acid, J. Biol. Chem., 274, 27776, 10.1074/jbc.274.39.27776 · DOI · Paper page
- Archbold, 2014, Towards selective lysophospholipid gpcr modulators, Trends Pharmacol. Sci., 35, 219, 10.1016/j.tips.2014.03.004 · doi:10.1016/j.tips.2014.03.004
- Choi, 2008, Biological roles of lysophospholipid receptors revealed by genetic null mice: An update, Biochim. Biophys. Acta, 1781, 531, 10.1016/j.bbalip.2008.03.004 · DOI
- Anliker, 2013, Lysophosphatidic acid (lpa) and its receptor, lpa1, influence embryonic schwann cell migration, myelination, and cell-to-axon segregation, Glia, 61, 2009, 10.1002/glia.22572 · DOI
- Sakai, 2013, Lpa1-induced cytoskeleton reorganization drives fibrosis through ctgf-dependent fibroblast proliferation, FASEB J. Off. Publ. Federation Am. Soc. Exp. Biol., 27, 1830, 10.1096/fj.12-219378 · DOI · Paper page
- Chrencik, 2015, Crystal structure of antagonist bound human lysophosphatidic acid receptor 1, Cell, 161, 1633, 10.1016/j.cell.2015.06.002 · DOI · Paper page
- Ohuchi, 2008, Expression patterns of the lysophospholipid receptor genes during mouse early development, Dev. Dyn., 237, 3280, 10.1002/dvdy.21736 · doi:10.1002/dvdy.21736
- Contos, 2002, Characterization of Lpa(2) (Edg4) and Lpa(1)/Lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: Signaling deficits without obvious phenotypic abnormality attributable to Lpa(2), Mol. Cell. Biol., 22, 6921, 10.1128/MCB.22.19.6921-6929.2002 · DOI · Paper page
- Xu, 2004, Trip6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor, J. Biol. Chem., 279, 10459, 10.1074/jbc.M311891200 · doi:10.1074/jbc.m311891200
- Lai, 2005, C-src-mediated phosphorylation of trip6 regulates its function in lysophosphatidic acid-induced cell migration, Mol. Cell. Biol., 25, 5859, 10.1128/MCB.25.14.5859-5868.2005 · doi:10.1128/mcb.25.14.5859-5868.2005
- Komachi, 2009, Lpa1 receptors mediate stimulation, whereas lpa2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites, Carcinogenesis, 30, 457, 10.1093/carcin/bgp011 · doi:10.1093/carcin/bgp011
- Hama, 2010, Lpa3, a unique g protein-coupled receptor for lysophosphatidic acid, Prog. Lipid Res., 49, 335, 10.1016/j.plipres.2010.03.001 · DOI
- Yanagida, 2011, Non-edg family lpa receptors: The cutting edge of lpa research, J. Biochem., 150, 223, 10.1093/jb/mvr087 · DOI
- Ishii, 2009, Non-edg family lysophosphatidic acid (lpa) receptors, Prostaglandins Lipid Mediat., 89, 57, 10.1016/j.prostaglandins.2009.06.001 · DOI
- Pamuklar, 2008, Individual heterogeneity in platelet response to lysophosphatidic acid: Evidence for a novel inhibitory pathway, Arterioscler. Thromb. Vasc. Biol., 28, 555, 10.1161/ATVBAHA.107.151837 · DOI
- Noguchi, 2003, Identification of p2y9/gpr23 as a novel g protein-coupled receptor for lysophosphatidic acid, structurally distant from the edg family, J. Biol. Chem., 278, 25600, 10.1074/jbc.M302648200 · DOI · Paper page
- Yanagida, 2013, Current progress in non-edg family lpa receptor research, Biochim. Biophys. Acta, 1831, 33, 10.1016/j.bbalip.2012.08.003 · DOI
- Sumida, 2010, Lpa4 regulates blood and lymphatic vessel formation during mouse embryogenesis, Blood, 116, 5060, 10.1182/blood-2010-03-272443 · DOI
- Yanagida, 2007, Lpa4/p2y9/gpr23 mediates rho-dependent morphological changes in a rat neuronal cell line, J. Biol. Chem., 282, 5814, 10.1074/jbc.M610767200 · doi:10.1074/jbc.m610767200
- Lee, 2008, Role of lpa(4)/p2y9/gpr23 in negative regulation of cell motility, Mol. Biol. Cell, 19, 5435, 10.1091/mbc.e08-03-0316 · DOI · Paper page
- Yanagida, 2009, Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/lpa6, J. Biol. Chem., 284, 17731, 10.1074/jbc.M808506200 · DOI · Paper page
- Pasternack, 2008, G protein-coupled receptor p2y5 and its ligand lpa are involved in maintenance of human hair growth, Nat. Genet., 40, 329, 10.1038/ng.84 · DOI · Paper page
- Araki, 2014, Inhibitory effects of lysophosphatidic acid receptor-5 on cellular functions of sarcoma cells, Growth Fact., 32, 117, 10.3109/08977194.2014.911294 · DOI
- Dong, 2014, Lysophosphatidic acid receptor-5 negatively regulates cellular responses in mouse fibroblast 3t3 cells, Biochem. Biophys. Res. Commun., 446, 585, 10.1016/j.bbrc.2014.03.016 · doi:10.1016/j.bbrc.2014.03.016
- Lee, 2015, Autotaxin and lpa1 and lpa5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis, Mol. Cancer Res. MCR, 13, 174, 10.1158/1541-7786.MCR-14-0263 · DOI
- Lee, 2009, P2y5 is a g(alpha)i, g(alpha)12/13 g protein-coupled receptor activated by lysophosphatidic acid that reduces intestinal cell adhesion, Am. J. Physiol. Gastrointest. Liver Physiol., 297, G641, 10.1152/ajpgi.00191.2009 · doi:10.1152/ajpgi.00191.2009
- Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cbioportal, Sci. Signal., 6, pl1, 10.1126/scisignal.2004088 · DOI · Paper page
- Schultze, 2011, Promiscuous affairs of pkb/akt isoforms in metabolism, Arch. Physiol. Biochem., 117, 70, 10.3109/13813455.2010.539236 · DOI · Paper page
- Yu, 2015, Akt isoforms in vascular disease, Vasc. Pharmacol., 71, 57, 10.1016/j.vph.2015.03.003 · DOI
- Dibble, 2009, A molecular link between akt regulation and chemotherapeutic response, Cancer Cell, 16, 178, 10.1016/j.ccr.2009.08.011 · DOI
- Newton, 2014, Turning off akt: Phlpp as a drug target, Annu. Rev. Pharmacol. Toxicol., 54, 537, 10.1146/annurev-pharmtox-011112-140338 · DOI · Paper page
- Sarbassov, 2005, Phosphorylation and regulation of akt/pkb by the rictor-mtor complex, Science, 307, 1098, 10.1126/science.1106148 · DOI · Paper page
- Jacinto, 2006, Sin1/mip1 maintains rictor-mtor complex integrity and regulates akt phosphorylation and substrate specificity, Cell, 127, 125, 10.1016/j.cell.2006.08.033 · DOI · Paper page
- Zeller, 2010, Pi3-kinase p110α mediates β1 integrin-induced akt activation and membrane protrusion during cell attachment and initial spreading, Cell Signal., 22, 1838, 10.1016/j.cellsig.2010.07.011 · DOI
- Riaz, A., Zeller, K.S., and Johansson, S. (2012). Receptor-specific mechanisms regulate phosphorylation of akt at ser473: Role of rictor in β1 integrin-mediated cell survival. PLoS ONE, 7. · DOI
- Fritsch, 2013, Ras and rho families of gtpases directly regulate distinct phosphoinositide 3-kinase isoforms, Cell, 153, 1050, 10.1016/j.cell.2013.04.031 · DOI · Paper page
- Santi, 2010, The akt isoforms are present at distinct subcellular locations, Am. J. Physiol., 298, C580, 10.1152/ajpcell.00375.2009 · DOI
- Villagrasa, 2012, Akt2 interacts with snail1 in the e-cadherin promoter, Oncogene, 31, 4022, 10.1038/onc.2011.562 · DOI
- Higuchi, 2008, Scaffolding function of pak in the pdk1-akt pathway, Nat. Cell Biol., 10, 1356, 10.1038/ncb1795 · DOI · Paper page
- Nakamura, 2008, Freud-1/aki1, a novel pdk1-interacting protein, functions as a scaffold to activate the pdk1/akt pathway in epidermal growth factor signaling, Mol. Cell. Biol., 28, 5996, 10.1128/MCB.00114-08 · DOI
- Luan, 2009, Deficiency of a β-arrestin-2 signal complex contributes to insulin resistance, Nature, 457, 1146, 10.1038/nature07617 · DOI · Paper page
- Chan, 2014, Posttranslational regulation of akt in human cancer, Cell Biosci., 4, 1, 10.1186/2045-3701-4-59 · DOI · Paper page
- Lim, 2012, Cyld negatively regulates transforming growth factor-β-signalling via deubiquitinating akt, Nat. Commun., 3, 771, 10.1038/ncomms1776 · DOI · Paper page
- Kang, 2004, Serum bioactive lysophospholipids prevent trail-induced apoptosis via pi3k/akt-dependent cflip expression and bad phosphorylation, Cell Death Differ., 11, 1287, 10.1038/sj.cdd.4401489 · DOI
- Kim, 2008, Lysophosphatidic acid induces cell migration through the selective activation of akt1, Exp. Mol. Med., 40, 445, 10.3858/emm.2008.40.4.445 · DOI
- Li, 2003, Lysophosphatidic acid promotes survival and differentiation of rat schwann cells, J.Biol. Chem., 278, 9585, 10.1074/jbc.M213244200 · DOI
- Murga, 2000, A novel role for phosphatidylinositol 3-kinase beta in signaling from g protein-coupled receptors to akt, J. Biol. Chem., 275, 12069, 10.1074/jbc.275.16.12069 · DOI · Paper page
- Baudhuin, 2002, Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific, Mol. Pharmacol., 62, 660, 10.1124/mol.62.3.660 · DOI
- Kihara, 2015, Lysophospholipid receptors in drug discovery, Exp. Cell Res., 333, 171, 10.1016/j.yexcr.2014.11.020 · DOI · Paper page
Cited by
Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities
Sanson, K. R., Hanna, R. E., Hegde, M., Donovan, K. F., Strand, C., Sullender, M. E., Vaimberg, E. W., Goodale, A., Root, D. E., Piccioni, F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07901-8 · Cited by 1,043
Metadata
- Authors
- Riaz, A., Huang, Y., & Johansson, S.
- Affiliations
- Institute of Biochemistry and Biotechnology, University of the Punjab, 54590 Lahore, Pakistan
- Department of Medical Biochemistry and Microbiology, Uppsala University, Biomedical Center, 75123 Uppsala, Sweden
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2016-02-05
- Volume
- 17
- Issue
- 2
- Pages
- 215
- ISSN
- 1422-0067
- Cited by
- 66
- References
- 3
- Language
- en
- Funders
- The Swedish Cancer Foundation (130362)
- The Higher Education Commission, Pakistan (02987/2008245)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: G-Protein-Coupled Lysophosphatidic Acid Receptors and Their Regulation of AKT Signaling. https://app.cochat.ai/papers/10.3390/ijms17020215
- The paper
- Riaz, A., Huang, Y., & Johansson, S. (2016). G-Protein-Coupled Lysophosphatidic Acid Receptors and Their Regulation of AKT Signaling. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms17020215
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.